Nectar Clinical Trial

Nectar Clinical Trial Finding new drugs to treat patients hospitalized with COVID-19. What is the NECTAR Study? The study is looking at new drugs to treat the virus.

NECTAR is a nationwide research study for people who are hospitalized with COVID-19. We want to see if these drugs help you get better by preventing or treating lung damage caused by COVID. Why is this study important? People are still becoming sick and hospitalized with COVID-19 and new treatments are needed to help fight the virus. Older adults, rural residents, those with other health conditions, and racially and ethnically diverse groups are more likely to be infected, hospitalized, or die from COVID-19. It is important to find out if these new drugs help people get better from COVID-19, especially those impacted the most. Joining the NECTAR Study is voluntary. If you join, you can leave the study at any time.

Address

1211 Medical Center Drive
Nashville, TN
37232

Telephone

+16153438010

Website

Alerts

Be the first to know and let us send you an email when Nectar Clinical Trial posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Nectar Clinical Trial:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category